Valneva SE Ownership
| VALN Stock | USD 7.36 0.05 0.67% |
Shares in Circulation | First Issued 2012-09-30 | Previous Quarter 131.5 M | Current Value 131.5 M | Avarage Shares Outstanding 81.6 M | Quarterly Volatility 34.6 M |
Valneva |
Valneva Stock Ownership Analysis
The book value of the company was at this time reported as 1.55. The company recorded a loss per share of 0.13. Valneva SE ADR had not issued any dividends in recent years. Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company was founded in 1998 and is headquartered in Saint-Herblain, France. Valneva Se is traded on NASDAQ Exchange in the United States. For more information please call Thomas Lingelbach at 33 2 28 07 37 10 or visit https://valneva.com.Besides selling stocks to institutional investors, Valneva SE also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Valneva SE's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Valneva SE's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Valneva SE Quarterly Liabilities And Stockholders Equity |
|
Valneva Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Valneva SE is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Valneva SE ADR backward and forwards among themselves. Valneva SE's institutional investor refers to the entity that pools money to purchase Valneva SE's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Qube Research & Technologies | 2024-09-30 | 0.0 | Advisor Group Holdings, Inc. | 2024-12-31 | 0.0 | General American Investors Co Inc | 2024-12-31 | 354.4 K | Wells Fargo & Co | 2024-12-31 | 246.8 K | Ironwood Investment Management Llc | 2024-12-31 | 25 K | Abc Arbitrage Sa | 2024-12-31 | 19.2 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 2.7 K | Ridgewood Investments Llc | 2024-12-31 | 550 | Alphamark Advisors, Llc | 2024-12-31 | 150 | Barclays Plc | 2024-12-31 | 10.0 | Hanson Mcclain Inc | 2024-12-31 | 7.0 |
Valneva SE Outstanding Bonds
Valneva SE issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Valneva SE ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Valneva bonds can be classified according to their maturity, which is the date when Valneva SE ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| VALMONT INDS INC Corp BondUS920253AF89 | View | |
| VALMONT INDS INC Corp BondUS920253AE15 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View |
Valneva SE Corporate Filings
6K | 18th of February 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
F3 | 20th of September 2024 An amendment to the original Schedule 13D filing | ViewVerify |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valneva SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.13) | Revenue Per Share | Quarterly Revenue Growth 0.204 | Return On Assets | Return On Equity |
The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.